---
title: Vaccine-associated axillary lymphadenopathy with a focus on COVID-19 vaccines
date: '2024-06-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38906159/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240622182948&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Axillary lymphadenopathy (LA) after COVID-19 vaccination is now known
  to be a common side effect. In these cases, malignancy cannot always be excluded
  on the basis of morphological imaging criteria.Narrative review for decision-making
  regarding control and follow-up intervals for axillary LA according to currently
  published research. This article provides a practical overview of the management
  of vaccine-associated LA using image examples and a flowchart and provides recommendations
  ...
disable_comments: true
---
Axillary lymphadenopathy (LA) after COVID-19 vaccination is now known to be a common side effect. In these cases, malignancy cannot always be excluded on the basis of morphological imaging criteria.Narrative review for decision-making regarding control and follow-up intervals for axillary LA according to currently published research. This article provides a practical overview of the management of vaccine-associated LA using image examples and a flowchart and provides recommendations ...